SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
TB AND OTHER OPPORTUNISTIC INFECTIONS
- Sort by:
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
8 of
8
|
A MULTICENTER DIAGNOSTIC ACCURACY STUDY OF THE XPERT ULTRA FOR TUBERCULOSIS DIAGNOSIS
Timothy Rodwell
FIND, Geneva, Switzerland
WHOLE-GENOME SEQUENCING AND SPATIAL ANALYSIS OF XDR TB TRANSMISSION IN SOUTH AFRICA
Kristin Nicole Nelson
Emory University, Atlanta, GA, USA
SIX-MONTH IPT REDUCES MORTALITY INDEPENDENTLY OF ART IN AFRICAN ADULTS WITH HIGH CD4
Anani D Badje
Inserm U1219, BORDEAUX, France
THE ESSENTIALITY OF INH DURING THE FIRST 14 DAYS OF TB THERAPY: THE A5307 EBA TRIAL
Florian von Groote-Bidlingmaier
TASK Applied Science, Cape Town, South Africa
THE NIX-TB TRIAL OF PRETOMANID, BEDAQUILINE AND LINEZOLID TO TREAT XDR-TB
Francesca Conradie
University of the WItswatersrand, Johannesburg, South Africa
RANDOMIZED CONTROLLED TRIAL OF PREDNISONE FOR PREVENTION OF PARADOXICAL TB-IRIS
Graeme Meintjes
University of Cape Town, South Africa, South Africa
AMBITION-CM: HIGH-DOSE LIPOSOMAL AMPHOTERICIN FOR HIV-RELATED CRYPTOCOCCAL MENINGITIS
Joseph N Jarvis
Center for Disease Control and Prevention, Gaborone, Botswana
A RANDOMISED CONTROLLED TRIAL OF INDUCTION THERAPY OF TALAROMYCES MARNEFFEI INFECTION
Thuy Le
Oxford University Clinical Research Unit, Vietnam, Ho Chi Minh, Viet Nam
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
8 of
8
|